News | Vena Cava Filters | September 09, 2020

Society of Interventional Radiology Publishes IVC Filter Guidelines

Multidisciplinary panel provides evidence-based recommendations on the use of inferior vena cava filters to treat venous thromboembolism

IVC filter guidelines. The Society of Interventional Radiology (SIR) published new inferior vena cava (IVC) filter guidelines.

September 9, 2020 — The Society of Interventional Radiology (SIR) published new clinical practice guidelines that provide evidence-based recommendations on the use of inferior vena cava (IVC) filters to treat venous thromboembolism (VTE).[1]

“These guidelines allow physicians treating patients at risk of a pulmonary embolism to make evidence-based decisions about the use of IVC filters,” said John A. Kaufman, M.D., MS, FSIR, the guidelines’ primary author and chair of the department of interventional radiology at Oregon Health and Science University in Portland. “Throughout the process, the multidisciplinary team followed a gold-standard methodology to ensure we reached the best possible consensus on VTE patient care.”

The guidelines advise against the routine placement of IVC filters in most VTE cases where patients are being successfully treated with anticoagulants. However, if anticoagulation therapies fail or are not indicated for the patient, IVC filters may be considered as a treatment option if clinical risk factors such as bleeding, vascular injury, device migration and increased risk of recurrent deep vein thrombosis (DVT) are considered and deemed low.

When IVC filters are placed, the guidelines recommend a follow-up program to increase retrieval and detect complications. In addition, if patients with retrievable IVC filters are no longer at risk of developing a pulmonary embolism (PE), the guidelines recommend removal unless the risk outweighs the benefits.

“With these multidisciplinary guidelines, the authors have removed any inconsistencies and uncertainties older guidelines may have presented physicians treating patients with VTE,” said SIR President Michael D. Dake, M.D., FSIR, senior vice president of the University of Arizona Health Sciences in Tucson. “The authors should be proud of this achievement.”

This is SIR's first official clinical practice guideline, developed using gold-standard guideline methodology following the Standards for Trustworthy Clinical Practice Guidelines set by the National Academy of Medicine. SIR is committed to continuing developing evidence-based clinical practice guidelines to optimize patient care and improve patient outcomes. 

Recommendation sections of the document with level of evidence noted include:

   • Acute PE
   • Acute DVT
   • Anticoagulation for VTE 
   • Recurrent VTE
   • Trauma Patients without Known VTE
   • Routine IVC Filter Placement PE with Advanced Therapies
   • DVT with Advanced Therapies
   • Major Surgery Patients without Known VTE
   • Indwelling IVC Filters with No Anticoagulation Indication
   • Indwelling IVC Filters with Mitigated PE Risk
   • Complications and Indwelling IVC Filters
   • Structured Follow-up
   • Planned Filter Removal
   • Filter Removal without Standard Snare Techniques
   • Filter Placement Technique

The guidelines were developed in collaboration with and endorsed by the American College of Cardiology (ACC), the American Heart Association/American Stroke Association, American College of Surgeons (Committee on Trauma), American College of Chest Physicians (CHEST), Society for Vascular Medicine, Society for Vascular Surgery. The Canadian Association for Interventional Radiology and Cardiovascular and Interventional Radiological Society of Europe have also endorsed the guidelines. The American Society of Hematology has affirmed the value of the statement.

Read the full guidelines on


About the Society of Interventional Radiology

The Society of Interventional Radiology (SIR) is a nonprofit, professional medical society representing more than 8,000 practicing interventional radiology physicians, trainees, students, scientists and clinical associates, dedicated to improving patient care through the limitless potential of image-guided therapies. SIR’s members work in a variety of settings and at different professional levels—from medical students and residents to university faculty and private practice physicians. Visit



1. John A. Kaufman, Geoffrey D. Barnes, Rabih A. Chaer, et al. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease. Journal of Vascular and Interventional Radiology. Article in press. Published online September 8, 2020. DOI:


Related Content

News | Cath Lab

March 14, 2023 — Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they ...

Home March 14, 2023
News | Cath Lab

March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home March 01, 2023
News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Subscribe Now